Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)

Navigation and Search

UTHealth Expert List

Topic: Stroke

Andrew  Barreto

Andrew Barreto,

  • Associate Professor, Department of Neurology, McGovern Medical School at UTHealth
  • Attending Physician, Mischer Neuroscience Institute, Memorial Hermann-Texas Medical Center

Research and clinical interests of Andrew D. Barreto, M.D., include combination treatments for thrombolysis, ultrasound-enhanced and endovascular treatments for stroke and CT and MRI vascular neuroimaging. He was lead author of a study showing that a hands-free ultrasound device in combination with tissue plasminogen activator (tPA) was safe. The results were published in the October 2013 issue of Stroke, the journal of the American Heart Association.

Previous Interview: http://www.houstonmatters.org/show/2013/11/19/houston-matters-for-tues-nov-19-2013

Nicole  Gonzales

Nicole Gonzales, M.D.

  • Associate Professor, Department of Neurology, McGovern Medical School at UTHealth
  • Attending Physician, Mischer Neuroscience Institute, Memorial Hermann-Texas Medical Center

Nicole R. Gonzales, M.D., researches neuroprotection in ischemic stroke, acute treatment of ischemic stroke and intracerebral hemorrhage, and stroke prevention and education. Her clinical interests include experimental treatments for intracerebral hemorrhage, neuroimaging and the natural history of intracerebral hemorrhage. She received the 2009 UTHealth Young Investigators Award for her work studying the medication pioglitazone for intracerebral hemorrhage.

Sean  Savitz

Sean Savitz, M.D.

  • Professor and Frank M. Yatsu, M.D. Chair in Neurology, McGovern Medical School at UTHealth
  • Director, Vascular Neurology Program and Fellowship, McGovern Medical School at UTHealth

Sean I. Savitz, M.D., specializes in the treatment and research of acute stroke. His research includes using autologous stem cells after acute stroke given intravenously and subacute stroke given by intra-carotid administration; using umbilical cord tissue-derived cells for acute ischemic stroke; and using tPA in patients who wake up with symptoms of stroke.

Return to Expert's List